Lakefront Biotherapeutics (GLPGF) Other Non-Current Assets (2013 - 2026)

Lakefront Biotherapeutics (GLPGF) has reported Other Non-Current Assets for 14 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 21.5% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 21.5% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, down 64.53% from the prior year.
• Other Non-Current Assets was $3.5 million for Q1 2026 at Lakefront Biotherapeutics, roughly flat from $3.4 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $5.9 billion in Q4 2022 and troughed at $2.8 million in Q1 2025.
• A 5-year average of $465.7 million and a median of $8.8 million in 2022 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slumped 99.71% in 2023 and surged 1063.14% in 2024, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $5.9 billion in 2022, then tumbled by 99.71% to $17.3 million in 2023, then tumbled by 46.18% to $9.3 million in 2024, then sank by 62.98% to $3.4 million in 2025, then increased by 0.41% to $3.5 million in 2026.
• The last three Other Non-Current Assets figures came in at $3.5 million (Q1 2026), $3.4 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.